SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027173
Filing Date
2016-11-03
Accepted
2016-11-03 08:31:53
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20160930.htm 10-Q 1771265
2 EX-31.1 sage-ex311_8.htm EX-31.1 9020
3 EX-31.2 sage-ex312_7.htm EX-31.2 8978
4 EX-32.1 sage-ex321_6.htm EX-32.1 10931
5 GRAPHIC g2016110302145633910202.jpg GRAPHIC 34933
  Complete submission text file 0001564590-16-027173.txt   5529878

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sage-20160930.xml EX-101.INS 1097340
7 XBRL TAXONOMY EXTENSION SCHEMA sage-20160930.xsd EX-101.SCH 40968
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20160930_cal.xml EX-101.CAL 33360
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20160930_def.xml EX-101.DEF 134309
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20160930_lab.xml EX-101.LAB 293683
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20160930_pre.xml EX-101.PRE 237245
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 161970276
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences